GL1X · GenesisL1 explorer

Research workbench

EGFR kinase domain mutant "tmlr" with a pyrazolopyrimidine inhibitor

Analyse EGFR kinase domain mutant "tmlr" with a pyrazolopyrimidine inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5HIB
Type
protein
Length
314 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Epidermal growth factor receptor
EC
2.7.10.1
UniProt
P00533
Ligands
63M
Pockets
3 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEpidermal growth factor receptor (EC 2.7.10.1)protein31437% helix, 19% strandP00533

Ligands and binding sites

  • 63M · N-tert-butyl-5-{[(1-methyl-1H-pyrazol-5-yl)sulfonyl]amino}pyrazolo[1,5-a]pyrimidine-3-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14230.640.784763M
21440.580.8319empty
31410.420.7527empty

Compared structures

  • 5HIB · EGFR kinase domain mutant TMLR" with a pyrazolopyrimidine inhibitor" · the same entry in another collection · chain A against A, TM-score 1.00
  • P00533 · AlphaFold monomer V2.0 prediction for epidermal growth factor receptor (P00533) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.